Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region

Background. Despite being a common infection in end-stage kidney disease patients, there are no evidence-based guidelines to suggest the ideal time of transplantation in patients on antitubercular therapy (ATT). This study aimed to examine the outcome of transplantation in patients while on ATT comp...

Full description

Bibliographic Details
Main Authors: Ashwini B. Gadde, MD, DNB, Pranaw Kumar Jha, MD, DNB, Shyam B. Bansal, MD, DM, Abhyudaysingh Rana, MD, DNB, Manish Jain, MD, DM, Dinesh Bansal, MD, DM, Dinesh Kumar Yadav, MD, DM, Amit Kumar Mahapatra, MD, DM, Sidharth Kumar Sethi, MD, FASN, Vijay Kher, MD, DM
Format: Article
Language:English
Published: Wolters Kluwer 2023-11-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001541
_version_ 1827631768781455360
author Ashwini B. Gadde, MD, DNB
Pranaw Kumar Jha, MD, DNB
Shyam B. Bansal, MD, DM
Abhyudaysingh Rana, MD, DNB
Manish Jain, MD, DM
Dinesh Bansal, MD, DM
Dinesh Kumar Yadav, MD, DM
Amit Kumar Mahapatra, MD, DM
Sidharth Kumar Sethi, MD, FASN
Vijay Kher, MD, DM
author_facet Ashwini B. Gadde, MD, DNB
Pranaw Kumar Jha, MD, DNB
Shyam B. Bansal, MD, DM
Abhyudaysingh Rana, MD, DNB
Manish Jain, MD, DM
Dinesh Bansal, MD, DM
Dinesh Kumar Yadav, MD, DM
Amit Kumar Mahapatra, MD, DM
Sidharth Kumar Sethi, MD, FASN
Vijay Kher, MD, DM
author_sort Ashwini B. Gadde, MD, DNB
collection DOAJ
description Background. Despite being a common infection in end-stage kidney disease patients, there are no evidence-based guidelines to suggest the ideal time of transplantation in patients on antitubercular therapy (ATT). This study aimed to examine the outcome of transplantation in patients while on ATT compared with those without tuberculosis (TB). Methods. This was a retrospective study. Renal transplant recipients transplanted while on ATT were compared with a 1:1 matched group (for age, sex, diabetic status, and type of induction agent) of patients without TB at the time of transplant. Patient outcomes included relapse of TB and graft and patient survival. Results. There were 71 patients in each group. The mean duration for which ATT was given pretransplant was 3.8 ± 2.47 mo. The average total duration of ATT received was 12.27 ± 1.25 mo. Mortality in both the groups was similar (8.4% in the TB group versus 4.5% in the non-TB group; P = 0.49). None of the surviving patients had recurrence of TB during the follow-up. Death-censored graft survival (98.5% in the TB group versus 97% in the non-TB group; P = 1) and biopsy-proven acute rejection rates (9.86% in the TB group versus 8.45% in the non-TB group; P = 1) were also similar in both the groups. Conclusions. Successful transplantation in patients with end-stage kidney disease on ATT is possible without any deleterious effect on patient and graft survival and no risk of disease recurrence. Multicentric prospective studies are needed.
first_indexed 2024-03-09T14:25:41Z
format Article
id doaj.art-46ca20df7ad04af1a266dba8c382886c
institution Directory Open Access Journal
issn 2373-8731
language English
last_indexed 2024-03-09T14:25:41Z
publishDate 2023-11-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj.art-46ca20df7ad04af1a266dba8c382886c2023-11-28T07:14:05ZengWolters KluwerTransplantation Direct2373-87312023-11-01911e154110.1097/TXD.0000000000001541202311000-00014Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic RegionAshwini B. Gadde, MD, DNB0Pranaw Kumar Jha, MD, DNB1Shyam B. Bansal, MD, DM2Abhyudaysingh Rana, MD, DNB3Manish Jain, MD, DM4Dinesh Bansal, MD, DM5Dinesh Kumar Yadav, MD, DM6Amit Kumar Mahapatra, MD, DM7Sidharth Kumar Sethi, MD, FASN8Vijay Kher, MD, DM91 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.1 Department of Nephrology and Renal Transplant, Medanta–The Medicity, Gurugram, India.Background. Despite being a common infection in end-stage kidney disease patients, there are no evidence-based guidelines to suggest the ideal time of transplantation in patients on antitubercular therapy (ATT). This study aimed to examine the outcome of transplantation in patients while on ATT compared with those without tuberculosis (TB). Methods. This was a retrospective study. Renal transplant recipients transplanted while on ATT were compared with a 1:1 matched group (for age, sex, diabetic status, and type of induction agent) of patients without TB at the time of transplant. Patient outcomes included relapse of TB and graft and patient survival. Results. There were 71 patients in each group. The mean duration for which ATT was given pretransplant was 3.8 ± 2.47 mo. The average total duration of ATT received was 12.27 ± 1.25 mo. Mortality in both the groups was similar (8.4% in the TB group versus 4.5% in the non-TB group; P = 0.49). None of the surviving patients had recurrence of TB during the follow-up. Death-censored graft survival (98.5% in the TB group versus 97% in the non-TB group; P = 1) and biopsy-proven acute rejection rates (9.86% in the TB group versus 8.45% in the non-TB group; P = 1) were also similar in both the groups. Conclusions. Successful transplantation in patients with end-stage kidney disease on ATT is possible without any deleterious effect on patient and graft survival and no risk of disease recurrence. Multicentric prospective studies are needed.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001541
spellingShingle Ashwini B. Gadde, MD, DNB
Pranaw Kumar Jha, MD, DNB
Shyam B. Bansal, MD, DM
Abhyudaysingh Rana, MD, DNB
Manish Jain, MD, DM
Dinesh Bansal, MD, DM
Dinesh Kumar Yadav, MD, DM
Amit Kumar Mahapatra, MD, DM
Sidharth Kumar Sethi, MD, FASN
Vijay Kher, MD, DM
Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
Transplantation Direct
title Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
title_full Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
title_fullStr Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
title_full_unstemmed Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
title_short Renal Transplantation in Patients With Tuberculosis: A Single-center Experience From an Endemic Region
title_sort renal transplantation in patients with tuberculosis a single center experience from an endemic region
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001541
work_keys_str_mv AT ashwinibgaddemddnb renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT pranawkumarjhamddnb renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT shyambbansalmddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT abhyudaysinghranamddnb renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT manishjainmddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT dineshbansalmddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT dineshkumaryadavmddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT amitkumarmahapatramddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT sidharthkumarsethimdfasn renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion
AT vijaykhermddm renaltransplantationinpatientswithtuberculosisasinglecenterexperiencefromanendemicregion